Relay Therapeutics, Inc. Common Stock

RLAYNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
13.52 USD
↘ 1.02 (7.02%)AT CLOSE (11:59 AM EDT)
13.23
↘ 0.29 (2.14%)
POST MARKET (AS OF 07:22 PM EDT)
Post Market
AS OF 07:22 PM EDT
13.23
↘ 0.29 (2.14%)
🔴Market: CLOSED
Open?$14.54
High?$14.54
Low?$12.93
Prev. Close?$14.54
Volume?6.1M
Avg. Volume?4.5M
VWAP?$13.36
Rel. Volume?1.35x
Bid / Ask
Bid?$12.93 × 1.5K
Ask?$13.52 × 100
Spread?$0.59
Midpoint?$13.23
Valuation & Ratios
Market Cap?2.9B
Shares Out?191.6M
Float?116.7M
Float %?65.3%
P/E Ratio?N/A
P/B Ratio?4.59
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A

Relay Therapeutics, Inc. Common Stock (RLAY) trades at $13.52 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, RLAY is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
192
Market Cap
2.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.relaytx.com
Listed
2020-07-16
Address
60 HAMPSHIRE STREET
CAMBRIDGE, MA 02139
Phone: 617-370-8837
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
25
Short Sent.?
14
Piotroski F-Score?1/9Weak
Altman Z-Score?26.30Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.70%Squeeze Risk
Short Interest?28.8M
Days to Cover?10.3
Free Float116.7M
Avg Daily Volume2.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?22.13Strong
Quick Ratio?22.13Strong
Cash Ratio?6.88Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
39
4.59FAIR▾
P/S?
Peers
100
S&P
3
275.97HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
256.81HIGH▾
Returns & Efficiency
ROE?
S&P
3
-42.5%WEAK▾
ROA?
S&P
3
-39.0%WEAK▾
Cash Flow & Enterprise
FCF?$-213383000
Enterprise Value?$2.7B
Fundamentals ratios updated end of day
MarketsMoversWatchlist